Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users

被引:8
|
作者
Li, Jan-Rong [1 ]
Gong, Rui-Yu
Tian, Kun-Lun
Wang, Ing
Wang, Yi-Xin
Huang, Han-U
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430030, Hubei Province, Peoples R China
[2] Dali Coll, Basic Med Dept, Dali 671000, Yunnan Province, Peoples R China
关键词
intravenous drug users; T lymphocyte subpopulation; blood-borne virus; co-infection; cytokine;
D O I
10.3748/wjg.v13.i16.2357
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the features of various blood-borne virus infections and co-infection in intravenous drug users (IDUs), and to examine the correlation of T lymphocyte subsets with virus co-infection. METHODS: Four hundred and six IDUs without any clinical manifestation of hepatitis and 102 healthy persons were enrolled in this study. HBV-DNA and HCV-RNA were detected by fluorescence quantitative PCR. HBsAg, HBeAg, anti-HBc, anti-HCV, HDV-Ag, anti-HGV, anti-HIV, and HCMV-IgM were assayed by enzyme-linked immunosorbent assay (ELISA) and immunochromatographic tests. The levels of Th1 and Th2 cytokines were measured by ELISA and radioactive immune assay (RIA). The T lymphocyte subpopulation was detected by using fluorescence immunoassay. The similar indices taken from the healthy persons served as controls. RESULTS: The viral infection rate among IDUs was 36.45% for HBV, 69.7% for HCV, 47.3% for HIV, 2.22% for HDV, 1.97% for HGV, and 3.45% for HCMV. The co-infection rate of blood-borne virus was detected in 255 of 406 (62.81%) IDUs. More than 80% (161/192) of subjects infected with HIV were co-infected with the other viruses, such as HBV, HCV. In contrast, among the controls, the infection rate was 17.65% for HBV and 0% for the other viruses. Our investigation showed that there was a profound decrease in the proportion of CD4/CD8 and the percentage of CD3 and CD4, but not in the percentage of CD8. The levels of PHA-induced cytokines (IFN-gamma and IL-4) and serum IL-2 were obviously decreased in IDUs. On the other hand, the level of serum IL-4 was increased. The level of IFN-gamma and the percentage of CD4 were continuously decreased when the IDUs were infected with HIV or HIV co-infection. IDUs with HIV and HBV co-infection was 15.1% (29/192). Of those 29 IDU with HIV and HBV co-infection, 51.72% (15/29) and 37.93% (11/29) were HBV-DNA-positive and HBeAg-positive, respectively. But, among IDUs without HIV infection, only 1.68% (2/119) of cases were HBV-DNA-positive. CONCLUSION: HCV, HBV and HIV infections are common in this population of IDU, leading to a high incidence of impaired Th1 cytokine levels and CD4 lymphocyte. IDUs with HIV and HBV/HCV co-infection have lower expression of Th1 cytokine with enhancement of the Th2 response. HIV may be causing HBV replication by decreasing Th1 function. (C) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2357 / 2362
页数:6
相关论文
共 50 条
  • [2] Incarceration is a major risk factor for blood-borne infection among intravenous drug users
    Mir-Nasseri, Mohammad Mehdi
    Mohammadkhani, Ashraf
    Tavakkoli, Hamid
    Ansari, Esmaeil
    Poustchi, Hossein
    HEPATITIS MONTHLY, 2011, 11 (01) : 19 - 22
  • [3] Changes in Blood-borne Infection Risk Among Injection Drug Users
    Mehta, Shruti H.
    Astemborski, Jacqueline
    Kirk, Gregory D.
    Strathdee, Steffanie A.
    Nelson, Kenrad E.
    Vlahov, David
    Thomas, David L.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (05): : 587 - 594
  • [4] Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan
    Ichimura, H
    Kurimura, O
    Tamura, I
    Tsukue, I
    Tsuchie, H
    Kurimura, T
    INTERNATIONAL JOURNAL OF STD & AIDS, 1995, 6 (06) : 441 - 443
  • [5] Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland
    Kucharska, Marta
    Inglot, Malgorzata
    Szymczak, Aleksandra
    Rymer, Weronika
    Zalewska, Malgorzata
    Malyszczak, Krzysztof
    Zaleska-Dorobisz, Urszula
    Kuliszkiewicz-Janus, Malgorzata
    HEPATITIS MONTHLY, 2016, 16 (09)
  • [6] Following the blood: Syringe reuse leads to blood-borne virus transmission among injection drug users
    Koester, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 : S139 - S140
  • [7] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    Wu, NP
    Li, D
    Zhu, B
    Zou, W
    CHINESE MEDICAL JOURNAL, 2003, 116 (09) : 1318 - 1320
  • [8] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    吴南屏
    李丹
    朱彪
    邹微
    中华医学杂志(英文版), 2003, (09) : 40 - 42
  • [9] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    吴南屏
    李丹
    朱彪
    邹微
    Chinese Medical Journal, 2003, (09)
  • [10] Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection
    Klester, Karolina
    Klester, Elena
    Shoikhet, Yakov
    Zharikov, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54